SMS Pharma Standalone December 2022 Net Sales at Rs 148.80 crore, up 22.72% Y-o-Y
March 14, 2023 / 11:26 IST
Reported Standalone quarterly numbers for SMS Pharmaceuticals are:Net Sales at Rs 148.80 crore in December 2022 up 22.72% from Rs. 121.25 crore in December 2021.
Quarterly Net Profit at Rs. 5.03 crore in December 2022 down 52.15% from Rs. 10.51 crore in December 2021.
EBITDA stands at Rs. 20.47 crore in December 2022 down 30.4% from Rs. 29.41 crore in December 2021.
SMS Pharma EPS has decreased to Rs. 0.59 in December 2022 from Rs. 1.24 in December 2021.
| SMS Pharma shares closed at 67.75 on March 13, 2023 (NSE) and has given -28.83% returns over the last 6 months and -30.01% over the last 12 months. |
| SMS Pharmaceuticals | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'22 | Sep'22 | Dec'21 | | Net Sales/Income from operations | 148.80 | 159.43 | 121.25 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 148.80 | 159.43 | 121.25 | | EXPENDITURE | | Consumption of Raw Materials | 75.74 | 87.69 | 100.44 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 21.89 | 28.20 | -39.27 | | Power & Fuel | -- | -- | -- | | Employees Cost | 13.57 | 13.06 | 13.21 | | Depreciation | 8.12 | 8.09 | 8.10 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 19.34 | 16.86 | 19.59 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 10.14 | 5.53 | 19.18 | | Other Income | 2.21 | 0.61 | 2.13 | | P/L Before Int., Excpt. Items & Tax | 12.35 | 6.14 | 21.31 | | Interest | 5.94 | 5.24 | 4.75 | | P/L Before Exceptional Items & Tax | 6.42 | 0.90 | 16.56 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 6.42 | 0.90 | 16.56 | | Tax | 1.39 | 0.11 | 6.06 | | P/L After Tax from Ordinary Activities | 5.03 | 0.79 | 10.51 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 5.03 | 0.79 | 10.51 | | Equity Share Capital | 8.47 | 8.47 | 8.47 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 0.59 | 0.09 | 1.24 | | Diluted EPS | 0.59 | 0.09 | 1.24 | | EPS After Extra Ordinary | | Basic EPS | 0.59 | 0.09 | 1.24 | | Diluted EPS | 0.59 | 0.09 | 1.24 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
